|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1982-9-17
|
|
pubmed:abstractText |
13-cis-retinoic acid was given with good results to 7 patients with exceptionally severe rosacea. Side effects were transitory and of minor consequence and subsided quickly on reduction of the dosage and topical application of mild cosmetics. The long-lasting remissions recorded to date indicate that 13-cis-retinoic acid may prove a new and successful approach to the treatment of rosacea.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0043-5325
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
115-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6213099-Administration, Topical,
pubmed-meshheading:6213099-Adult,
pubmed-meshheading:6213099-Aged,
pubmed-meshheading:6213099-Female,
pubmed-meshheading:6213099-Humans,
pubmed-meshheading:6213099-Isotretinoin,
pubmed-meshheading:6213099-Male,
pubmed-meshheading:6213099-Middle Aged,
pubmed-meshheading:6213099-Rosacea,
pubmed-meshheading:6213099-Tetracyclines,
pubmed-meshheading:6213099-Tretinoin
|
|
pubmed:year |
1982
|
|
pubmed:articleTitle |
[13-Cis-retinoic acid: a new form of treatment of rosacea (author's transl)].
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
